Literature DB >> 18945768

Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein.

Julia G Prado1, Isobella Honeyborne, Ian Brierley, Maria Carmen Puertas, Javier Martinez-Picado, Philip J R Goulder.   

Abstract

The observed association between HLA-B*13 and control of human immunodeficiency virus type 1 (HIV-1) infection has been linked to the number of Gag-specific HLA-B*13-restricted cytotoxic T-cell (CTL) responses identified. To date, the Gag escape mutations described that result in an in vitro fitness cost to the virus have been located within structural protein p24 only. Here we investigated the hypothesis that CTL escape mutations within other regions of HIV Gag may also reduce viral fitness and contribute to immune control. We analyzed an HLA-B*13-restricted CTL response toward an epitope in p1 Gag, RQANFLGKI(429-437) (RI9), where amino acid variation at Gag residues 436 and 437 is associated with HLA-B*13 expression. In this work, we assessed the impact of amino acid substitutions at these positions on CTL recognition and on HIV-1 fitness. We demonstrated that substitutions I437L and I437M largely abrogate CTL recognition and reduce viral fitness while variants K436R and I437V have only a marginal effect on recognition and fitness. Examination of the patterns of protein synthesis indicated that the loss of fitness in the I437L and I437M mutants is associated with the accumulation of unprocessed Gag precursors. A significant reduction in ribosomal frameshifting efficiency was observed with I437M, suggesting that this mechanism contributes to the observed reduced fitness of this virus. These studies illustrate the apparent trade-off available to the virus between evasion of CTL recognition in p1 Gag and the functional consequences for viral fitness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945768      PMCID: PMC2612351          DOI: 10.1128/JVI.01882-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  HLA and AIDS: a cautionary tale.

Authors:  S J O'Brien; X Gao; M Carrington
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

2.  Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M.

Authors:  Martin Baril; Dominic Dulude; Karine Gendron; Guy Lemay; Léa Brakier-Gingras
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

Review 3.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Authors:  M Shehu-Xhilaga; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability.

Authors:  Melissa K Hill; Miranda Shehu-Xhilaga; Suzanne M Crowe; Johnson Mak
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.

Authors:  Bradley H Edwards; Anju Bansal; Steffanie Sabbaj; Janna Bakari; Mark J Mulligan; Paul A Goepfert
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses.

Authors:  David H O'Connor; Bianca R Mothe; Jason T Weinfurter; Sarah Fuenger; William M Rehrauer; Peicheng Jing; Richard R Rudersdorf; Max E Liebl; Kendall Krebs; Joshua Vasquez; Elizabeth Dodds; John Loffredo; Sarah Martin; Adrian B McDermott; Todd M Allen; Chenxi Wang; G G Doxiadis; David C Montefiori; Austin Hughes; Dennis R Burton; David B Allison; Steven M Wolinsky; Ronald Bontrop; Louis J Picker; David I Watkins
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure.

Authors:  Amalio Telenti; Raquel Martinez; Miguel Munoz; Gabriela Bleiber; Gilbert Greub; Dominique Sanglard; Solange Peters
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Structure-function analysis of the ribosomal frameshifting signal of two human immunodeficiency virus type 1 isolates with increased resistance to viral protease inhibitors.

Authors:  Roseanne Girnary; Louise King; Laurence Robinson; Robert Elston; Ian Brierley
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

View more
  33 in total

1.  Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.

Authors:  Mark A Brockman; Denis R Chopera; Alex Olvera; Chanson J Brumme; Jennifer Sela; Tristan J Markle; Eric Martin; Jonathan M Carlson; Anh Q Le; Rachel McGovern; Peter K Cheung; Anthony D Kelleher; Heiko Jessen; Martin Markowitz; Eric Rosenberg; Nicole Frahm; Jorge Sanchez; Simon Mallal; Mina John; P Richard Harrigan; David Heckerman; Christian Brander; Bruce D Walker; Zabrina L Brumme
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Partial escape of HIV-1 from cytotoxic T lymphocytes during chronic infection.

Authors:  Martha J Lewis; Mirabelle Dagarag; Basim Khan; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

4.  Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.

Authors:  Vitaly V Ganusov; Nilu Goonetilleke; Michael K P Liu; Guido Ferrari; George M Shaw; Andrew J McMichael; Persephone Borrow; Bette T Korber; Alan S Perelson
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

5.  CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.

Authors:  Catherine K Koofhethile; Zaza M Ndhlovu; Christina Thobakgale-Tshabalala; Julia G Prado; Nasreen Ismail; Zenele Mncube; Lungile Mkhize; Mary van der Stok; Nonhlanhla Yende; Bruce D Walker; Philip J R Goulder; Thumbi Ndung'u
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

6.  Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.

Authors:  Rebecca P Payne; Henrik Kløverpris; Jonah B Sacha; Zabrina Brumme; Chanson Brumme; Søren Buus; Stuart Sims; Stephen Hickling; Lynn Riddell; Fabian Chen; Graz Luzzi; Anne Edwards; Rodney Phillips; Julia G Prado; Philip J R Goulder
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

7.  Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.

Authors:  Blake Schouest; Andrea M Weiler; Sanath Kumar Janaka; Tereance A Myers; Arpita Das; Sarah C Wilder; Jessica Furlott; Melody Baddoo; Erik K Flemington; Eva G Rakasz; David T Evans; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

8.  Immune-mediated attenuation of HIV-1.

Authors:  Denis R Chopera; Jaclyn K Wright; Mark A Brockman; Zabrina L Brumme
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

9.  Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships.

Authors:  Jianming Tang; Rakhi Malhotra; Wei Song; Ilene Brill; Liangyuan Hu; Paul K Farmer; Joseph Mulenga; Susan Allen; Eric Hunter; Richard A Kaslow
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.

Authors:  Christina A Semeniuk; Lyle McKinnon; Harold O Peters; Michael Gubbins; Xiaojuan Mao; Terry B Ball; Ma Luo; Francis A Plummer
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.